# Trial Quality Validation Summary

## 🎯 Purpose

Validate that our bulk seeding strategy is finding "good" trials, not just quantity.

## 📊 Current Quality Assessment

### Overall Database Quality (Sample of 200 trials)

- **Mean Quality Score**: 0.758
- **Quality Distribution**:
  - Excellent (≥0.9): 8.5%
  - Good (0.7-0.9): 43.5%
  - Fair (0.5-0.7): 48.0%
  - Poor (<0.5): 0.0%

### Category Scores

- **Essential Fields**: 0.848 ✅ (Good - most required fields present)
- **Data Quality**: 0.857 ✅ (Good - valid data structure)
- **Actionability**: 0.690 ⚠️ (Fair - missing location/PI data)
- **Clinical Relevance**: 0.649 ⚠️ (Fair - many non-recruiting trials)

### Status Breakdown

- **COMPLETED**: 45.5% (too many - should focus on active trials)
- **RECRUITING**: 22.0% (good, but could be higher)
- **NOT_YET_RECRUITING**: 4.5%
- **UNKNOWN**: 14.5% (data quality issue)

## 🔍 Strategy Comparison Results

### Best Strategies (Ranked by Quality Score)

1. **Phase 2 Recruiting** (All cancers)
   - Mean Score: **0.959** ✅
   - Excellent Trials: **62.1%**
   - Count: 161 trials
   - **RECOMMENDATION**: Focus on Phase 2 recruiting trials

2. **Phase 3 Recruiting** (All cancers)
   - Mean Score: **0.945** ✅
   - Excellent Trials: **48.0%**
   - Count: 50 trials
   - **RECOMMENDATION**: Include Phase 3 recruiting trials

3. **All Recruiting** (All cancers, all phases)
   - Mean Score: **0.901** ✅
   - Excellent Trials: **41.6%**
   - Count: 437 trials
   - **RECOMMENDATION**: Good baseline strategy

4. **All Trials** (No filters)
   - Mean Score: **0.810** ⚠️
   - Excellent Trials: **14.8%**
   - Count: 1,397 trials
   - **RECOMMENDATION**: Too many low-quality trials

### Poor Strategies

- **Ovarian-specific**: Only 9 trials found, 0 recruiting
  - **ISSUE**: Too narrow - not enough volume
  - **RECOMMENDATION**: Expand to all cancers, filter by condition in post-processing

## 💡 Key Insights

### ✅ What's Working

1. **Phase 2/3 Recruiting trials are excellent quality** (0.959-0.945 mean score)
2. **Recruiting status is a strong quality indicator** (0.901 vs 0.810 overall)
3. **Data extraction is working** (0.848 essential fields score)
4. **No poor-quality trials** (0% below 0.5 threshold)

### ⚠️ What Needs Improvement

1. **Too many completed trials** (45.5%) - should focus on active trials
2. **Low actionability scores** (0.690) - missing location/PI data
3. **Ovarian-specific too narrow** - only 9 trials, 0 recruiting
4. **Clinical relevance could be higher** (0.649) - need more recruiting trials

## 📋 Recommendations

### 1. **Prioritize Phase 2/3 Recruiting Trials**

**Action**: Update bulk seeding script to prioritize:
- Phase 2 recruiting: Target 2,000 trials
- Phase 3 recruiting: Target 1,000 trials
- All recruiting: Target 3,000 trials

**Expected Impact**: 
- Mean quality score: 0.90+ (vs current 0.76)
- Excellent trials: 50%+ (vs current 8.5%)

### 2. **Filter Out Completed Trials**

**Action**: Add status filter to exclude COMPLETED, TERMINATED, WITHDRAWN

**Expected Impact**:
- Increase recruiting percentage from 22% to 60%+
- Improve clinical relevance score from 0.649 to 0.80+

### 3. **Expand Beyond Ovarian-Only**

**Action**: Use broader queries (all cancers), filter by condition in post-processing

**Expected Impact**:
- More volume (1,000+ vs 9 trials for ovarian)
- Better quality (0.90+ vs 0.76 for ovarian-only)

### 4. **Enhance Actionability Data**

**Action**: Improve location and PI extraction in data enrichment

**Expected Impact**:
- Actionability score: 0.80+ (vs current 0.69)
- More trials with location data

## 🎯 Updated Seeding Strategy

### Recommended Query Priorities

1. **Phase 2 Recruiting** (All cancers) - 2,000 trials
2. **Phase 3 Recruiting** (All cancers) - 1,000 trials  
3. **Phase 1/2/3 Recruiting** (All cancers) - 3,000 trials
4. **DNA Repair Focus** (PARP, ATR inhibitors) - 1,000 trials
5. **Immunotherapy** (Checkpoint inhibitors) - 1,500 trials
6. **Basket Trials** - 500 trials
7. **Precision Medicine** - 800 trials

**Total Target**: ~10,000 trials
**Expected Quality**: Mean score 0.85-0.90, 40-50% excellent

### Quality Thresholds

- **Minimum Acceptable**: 0.70 mean score
- **Target**: 0.85+ mean score
- **Excellent**: 0.90+ mean score, 40%+ excellent trials

## 🔧 Tools Created

1. **`validate_trial_quality.py`**: Assesses quality of trials in database
   - Usage: `python3 scripts/validate_trial_quality.py --sample --limit 200`

2. **`compare_seeding_strategies.py`**: Compares different seeding strategies
   - Usage: `python3 scripts/compare_seeding_strategies.py`

## 📈 Next Steps

1. ✅ **Run quality validation** on current database
2. ✅ **Compare strategies** to identify best approaches
3. ⏸️ **Update bulk seeding script** with prioritized strategies
4. ⏸️ **Re-run seeding** with improved strategy
5. ⏸️ **Re-validate** to confirm quality improvement

## 🎉 Success Criteria

- **Mean Quality Score**: ≥0.85
- **Excellent Trials**: ≥40%
- **Recruiting Trials**: ≥60% of total
- **Actionability Score**: ≥0.75
- **No Poor Trials**: 0% below 0.5 threshold











